- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
U.S. Diagnostic, Steel Partners sign stock deal
Radiology services firm U.S. Diagnostic has signed an agreement with Steel Partners II that allows Steel Partners to purchase up to 45% of U.S. Diagnostic’s voting stock without prior board approval. Steel Partners already owns approximately 15% of
Radiology services firm U.S. Diagnostic has signed an agreement with Steel Partners II that allows Steel Partners to purchase up to 45% of U.S. Diagnostics voting stock without prior board approval. Steel Partners already owns approximately 15% of U.S. Diagnostics stock.
The move comes as West Palm Beach, FL-based U.S. Diagnostic seeks to bolster its business. In the first three quarters of 1999, the company sold its underperforming facilities in Texas (SCAN 3/3/99) and fell from its first place position in the imaging center market to third, according to a report by SMG Marketing Group of Chicago (SCAN 1/19/00).
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
